Clinical Trial Update: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of povorcitinib in participants with inadequately controlled moderate to severe asthma is actively r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Povorcitinib (povorcitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Moderate to Severe Asthma | Phase 2 | Status: RECRUITING